$2.25 Thousand is the total value of Cyrus J. Lawrence, LLC's 129 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | New | Merck & Co Incus equities | $9,218 | – | 89,544 | +100.0% | 2.53% | – |
| BLK | New | Blackrock Incus equities | $5,641 | – | 8,726 | +100.0% | 1.55% | – |
| NVO | New | Novo Nordisk A/S ADRus equities | $5,602 | – | 61,612 | +100.0% | 1.54% | – |
| New | Kenvue Inc.us equities | $88 | – | 4,398 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp | 7 | Q3 2023 | 8.2% |
| Apple Inc | 7 | Q3 2023 | 5.7% |
| Edwards Lifesciences Corp | 7 | Q3 2023 | 24.5% |
| Alphabet Inc. Class A | 7 | Q3 2023 | 4.2% |
| Adobe Inc | 7 | Q3 2023 | 12.5% |
| Palo Alto Networks Inc | 7 | Q3 2023 | 3.9% |
| NextEra Energy Inc | 7 | Q3 2023 | 3.4% |
| Amazon.com Inc | 7 | Q3 2023 | 3.5% |
| Costco Wholesale Co | 7 | Q3 2023 | 2.9% |
| Johnson & Johnson | 7 | Q3 2023 | 2.9% |
View Cyrus J. Lawrence, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-04-27 |
View Cyrus J. Lawrence, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.